The Swedish biopharmaceutical company BioArctic Neuroscience AB is developing a novel treatment for complete spinal cord injury. This project has received funding (6.4 M€) from the ...
In September 2014, VINNOVA announced that BioArctic Neuroscience AB together with the Ångström Laboratory, Department of Engineering Sciences, Uppsala University, and Psilox AB were granted up ...
The US patent office has granted BioArctic a US patent (US 8809506) covering therapeutic and diagnostic antibodies for Parkinson’s disease and Dementia with Lewy Bodies.
...
The US patent office has granted a BioArctic patent for protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's Disease, Dementia with Lewy ...
BioArctic´s mission is to provide new and effective treatments for patients with disorders in the Central Nervous System. The company has evolved in a very positive ...